According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are NZ$14.91 Billion. In 2025 the company made an earning of NZ$8.80 Billion, an increase over its 2024 earnings that were of NZ$8.04 Billion. The earnings displayed on this page is the company's Pretax Income.